Qualigen Therapeutics Statistics
Total Valuation
QLGN has a market cap or net worth of $3.33 million. The enterprise value is $4.26 million.
| Market Cap | 3.33M |
| Enterprise Value | 4.26M |
Important Dates
The next estimated earnings date is Tuesday, August 13, 2024, before market open.
| Earnings Date | Aug 13, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
QLGN has 11.38 million shares outstanding. The number of shares has increased by 19.86% in one year.
| Shares Outstanding | 11.38M |
| Shares Change (YoY) | +19.86% |
| Shares Change (QoQ) | +13.74% |
| Owned by Insiders (%) | 5.98% |
| Owned by Institutions (%) | 2.31% |
| Float | 9.59M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.05 |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.62 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.22
| Current Ratio | 0.22 |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -9.42 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -227.60% |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | $406,758 |
| Profits Per Employee | -$2.92M |
| Employee Count | 4 |
| Asset Turnover | 0.32 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -41,189 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -71.57% in the last 52 weeks. The beta is 0.08, so QLGN's price volatility has been lower than the market average.
| Beta (5Y) | 0.08 |
| 52-Week Price Change | -71.57% |
| 50-Day Moving Average | 0.25 |
| 200-Day Moving Average | 0.48 |
| Relative Strength Index (RSI) | 53.86 |
| Average Volume (20 Days) | 37,685,247 |
Short Selling Information
The latest short interest is 571,453, so 5.02% of the outstanding shares have been sold short.
| Short Interest | 571,453 |
| Short Previous Month | 96,269 |
| Short % of Shares Out | 5.02% |
| Short % of Float | 5.96% |
| Short Ratio (days to cover) | 0.18 |
Income Statement
In the last 12 months, QLGN had revenue of $1.63 million and -$11.66 million in losses. Loss per share was -$2.23.
| Revenue | 1.63M |
| Gross Profit | 610,489 |
| Operating Income | -10.03M |
| Pretax Income | -11.64M |
| Net Income | -11.66M |
| EBITDA | -10.64M |
| EBIT | -10.53M |
| Loss Per Share | -$2.23 |
Balance Sheet
The company has $93,217 in cash and $1.02 million in debt, giving a net cash position of -$929,652 or -$0.08 per share.
| Cash & Cash Equivalents | 93,217 |
| Total Debt | 1.02M |
| Net Cash | -929,652 |
| Net Cash Per Share | -$0.08 |
| Equity (Book Value) | -3.52M |
| Book Value Per Share | -0.31 |
| Working Capital | -3.52M |
Cash Flow
In the last 12 months, operating cash flow was -$8.45 million and capital expenditures $198,009, giving a free cash flow of -$8.26 million.
| Operating Cash Flow | -8.45M |
| Capital Expenditures | 198,009 |
| Free Cash Flow | -8.26M |
| FCF Per Share | -$1.39 |
Margins
Gross margin is 37.52%, with operating and profit margins of -616.17% and -716.87%.
| Gross Margin | 37.52% |
| Operating Margin | -616.17% |
| Pretax Margin | -715.72% |
| Profit Margin | -716.87% |
| EBITDA Margin | -653.93% |
| EBIT Margin | -647.06% |
| FCF Margin | -507.41% |
Dividends & Yields
QLGN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -19.86% |
| Shareholder Yield | -19.86% |
| Earnings Yield | -349.96% |
| FCF Yield | -247.71% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on November 23, 2022. It was a reverse split with a ratio of 1:10.
| Last Split Date | Nov 23, 2022 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
QLGN has an Altman Z-Score of -202.62 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -202.62 |
| Piotroski F-Score | 3 |